ROBERT C. HINMAN, M.D.; KENNETH R. MAGEE, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
Classification of the Guillain-Barré syndrome has been the subject of much discussion and review (1-11). The diversity of the clinical manifestations has led some clinicians to establish criteria that would more precisely delimit the syndrome (1). Others take issue with this restrictive tendency, believing that it excludes certain clinical manifestations such as profound sensory loss, relapses, and ataxia that should be considered part of the syndrome (2-5, 12). This attempt at restrictive classification of the syndrome would be securely based if the etiologic mechanism(s) were understood. Despite the widely accepted parainfectious etiologic component, it is rarely possible to establish a
HINMAN RC, MAGEE KR. Guillain-Barré Syndrome with Slow Progressive Onset and Persistent Elevation of Spinal Fluid Protein. Ann Intern Med. ;67:1007–1012. doi: 10.7326/0003-4819-67-5-1007
Download citation file:
Published: Ann Intern Med. 1967;67(5):1007-1012.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use